pyrroles has been researched along with palbociclib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaser, BW; Briesewitz, R; Caligiuri, MA; Duchemin, AM; Kusewitt, DF; Liu, T; Wang, J; Wang, L | 1 |
| Acharya, P; Hiebert, SW; Liu, Q; Sampathi, S; Savona, MR; Stengel, KR; Wang, J; Zhao, Y | 1 |
| Baal, N; Dorfmuller, P; Ghofrani, HA; Grimminger, F; Jonigk, D; Kojonazarov, B; Neubauer, MC; Neubert, L; Pullamsetti, SS; Ruppert, C; Schermuly, RT; Schlueter, BC; Seeger, W; Weiss, A; Weissmann, N; Yerabolu, D | 1 |
3 other study(ies) available for pyrroles and palbociclib
| Article | Year |
|---|---|
Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia.
Topics: Acute Disease; Animals; Blotting, Western; Bone Marrow Cells; Cell Proliferation; Cyclin D2; Cyclin D3; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; fms-Like Tyrosine Kinase 3; G1 Phase; Humans; Immunoprecipitation; Indoles; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid; Mice; Mice, SCID; Morpholines; Mutation; Phosphorylation; Piperazines; Pyridines; Pyrroles; Retinoblastoma Protein; Signal Transduction; Tumor Cells, Cultured | 2007 |
The CDK7 inhibitor THZ1 alters RNA polymerase dynamics at the 5' and 3' ends of genes.
Topics: 3' Flanking Region; 5' Flanking Region; Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Cyclic N-Oxides; Cyclin-Dependent Kinase 9; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Flavonoids; Gene Expression Regulation, Leukemic; Humans; Indolizines; Myeloid Cells; Phenylenediamines; Piperazines; Piperidines; Piperidones; Protein Kinase Inhibitors; Pyridines; Pyridinium Compounds; Pyrimidines; Pyrroles; RNA Polymerase II; Translocation, Genetic | 2019 |
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension.
Topics: Animals; Cell Line; Cyclin-Dependent Kinases; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Indoles; Lung; Male; Mice; Mice, Inbred C57BL; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Piperazines; Protein Kinase Inhibitors; Pulmonary Artery; Pyridines; Pyrroles; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Treatment Outcome | 2019 |